Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is spending $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own.The New York...
More from Connecticut Non-Local Sources
NY Times on Connecticut
His Unmarked Grave Lay Forgotten for 200 Years. They Had to Fix That.
Connecticut Non-Local Sources
•
Oct 9, 2026
NY Times on Connecticut
Homes for Sale in New York and Connecticut
Connecticut Non-Local Sources
•
Oct 8, 2026
NY Times on Connecticut
Should Robert Rauschenberg's Art Studio Be Saved?
Connecticut Non-Local Sources
•
Oct 6, 2026
NY Times on Connecticut
Where High Rents Drive People Into Poverty
Connecticut Non-Local Sources
•
Sep 29, 2026
NY Times on Connecticut
Nor'easter Weakens but Remains a Threat
Connecticut Non-Local Sources
•
Sep 28, 2026
NY Times on Connecticut
In Coastal Towns, the Nor'easter Upended Wedding Plans
Connecticut Non-Local Sources
•
Sep 26, 2026
NY Times on Connecticut
American Yom Kippur: How Jews Across the U.S. Observe the Holiest Day of the Year
Connecticut Non-Local Sources
•
Sep 20, 2026